Regulatory News
Wednesday, May 18, 2016
BRIEF-Health Canada authorizes ProMetic to proceed with PBI-4050 clinical trial
May 18 (Reuters) - ProMetic Life Sciences Inc Says To
Commence Clinical Trial Of Its Orally Active Anti
Read more
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment